After gathering substantial evidence from patients whose lives have changed dramatically, the team at Amorphical is thrilled to announce a groundbreaking discovery that has brought considerable relief to individuals suffering from Crohn’s disease, colitis, and other chronic inflammatory diseases.
The constant challenges faced by patients with inflammatory bowel diseases—frequent restroom visits, diarrhea, isolation, dietary restrictions, and the overall struggle to maintain a normal life—have always been at the forefront of our scientists’ minds. In response to these challenges, we have recently expanded our production capacity, enabling us to offer our innovative solution, PH Gastrilex, internationally for the first time beyond the borders of Israel. This remarkable development is specifically designed to provide relief and support for individuals experiencing the pain and discomfort associated with Crohn’s disease and colitis. Below, you will find testimonials from people whose lives have been significantly transformed by PH Gastrilex, alongside an explanation of the unique approaches that differentiate our product from any other on the market.